About BioAgilytix
BioAgilytix is a Healthcare company based in Durham (United States) founded in 2008, and was acquired by Cinven in November 2021. Large-molecule bioanalysis is provided for biologics and biosimilars development. BioAgilytix has completed 4 acquisitions, including 360biolabs, Cambridge Biomedical and IPM Biotech. Its website bioagilytix.com draws about 42 thousand monthly visits. BioAgilytix offers products and services including Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is BIOAGILYTIX LABS, INC. Its competitors include Advion, Evans Analytical Group and ApoCell; 1 of its 3 listed competitors has raised funding.
Company details
BioAgilytix was founded in 2008 and is headquartered in Durham, North Carolina, within the Research Triangle Park area. Operations are conducted as a bioanalytical contract research organization in the biotechnology sector. Services encompass assay development, validation, and sample analysis for immunoassays and cell-based assays, performed under non-GLP, spirit-of-GLP, and GLP guidelines. GMP-compliant product release testing is also handled to support clinical trials for therapeutic biologics and biosimilars.
- InvestorsGHO Capital
& 3 more
- Investments & Acquisitions360biolabs
& 3 more
- Acquired by
Products & Services of BioAgilytix
BioAgilytix offers a comprehensive portfolio of products and services, including Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing.
Streamlines processes for successful assay method transfers in development.
Develops and validates custom assays for bioanalytical needs.
Provides accurate analysis of samples for preclinical and clinical trials.
Produces customized specimen collection kits for clinical trials.
Offers testing for infectious diseases and immunology diagnostics.
Apps and channels of BioAgilytix
its YouTube channel BioAgilytix has 457 subscribers and 30 videos.
Videos from BioAgilytix
The most watched videos on BioAgilytix's YouTube channel, BioAgilytix (457 subscribers). Click a video to play it here.
More on BioAgilytix.
Funding Insights of BioAgilytix
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of BioAgilytix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2019 | Series A | – | GHO Capital Partners | – |
4 investors in total: 4 institutional.
Investors in BioAgilytix
BioAgilytix has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include GHO Capital, Riverside Partners and Cobepa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialist healthcare investment advisory services are provided by GHO Capital. | ghocapital.com | London, United Kingdom | ||
Private equity investments are made in technology and healthcare sectors. | riversidepartners.com | Boston, United States | ||
Cobepa is recognized as an independent investment company. | cobepa.com | Brussels, Belgium | ||
Private equity investments and portfolio management services are provided by Cinven across various sectors. | cinven.com |
Investor details for BioAgilytix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioAgilytix
154 people are tracked at BioAgilytix (48 in leadership, 106 in team).
| Name | Role | Group |
|---|---|---|
Stephane De Fortescu | VP, Business Development in Europe | Leadership |
Michelle Mason | Director, Project Services | Leadership |
Kevin J. Burns | Director, Business Development | Leadership |
Scott Geller | Vice President Of Finance And Operations | Leadership |
Euan Menzies | Chairman & CEO | Leadership |
Linda Robbie | COO | Leadership |
Teresa Neal | Head Of Global Procurement | Leadership |
Marco Klinge | Associate Director Bioanalytical Operations | Leadership |
Maureen Marchek | CFO | Leadership |
Alistair Draffan | President, 360biolabs | Leadership |
Kathryn Lindley | VP & General Manager, BioAgilytix Durham | Leadership |
Thomas J. Schneider | Director, Scientific Services | Leadership |
Jeffrey Patrick | Sr Director | Leadership |
Robert Nelson | Scientific Officer, Senior Director | Leadership |
Natalie Smith | CLIA Laboratory Director | Leadership |
Jennifer M. Zemo | Vice President Quality Assurance | Leadership |
Shashank Gorityala | Associate Director, Head Of Large Molecule Mass Spectrometry Core Services, Bioanalytical Sciences | Leadership |
Jennifer T Durham | Associate Director Of Scientific Services | Leadership |
Mark Spengler | Senior Director Business Development | Leadership |
Sarah Rieveschl | Executive Director, Strategic Accounts | Leadership |
134 more people are available in the full profile.
Complete people profiles for BioAgilytix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioAgilytix
BioAgilytix has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include 360biolabs, Cambridge Biomedical and IPM Biotech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CRO specialising in bioanalysis & DMPK assays | microconstants.com | San Diego, United States | 1998 | Aug 2021 | •••• | |
Contract virology and immunology services are provided by 360biolabs. | 360biolabs.com | Melbourne, Australia | 2015 | Aug 2021 | •••• | |
Bioanalytical and diagnostic testing services are provided for life sciences. | cambridgebiomedical.com | Boston, United States | 1997 | Nov 2019 | •••• | |
Biomarkers, cytometry, PCR, and ELISA machines are manufactured. | ipm-biotech.de | Hamburg, Germany | 2008 | Feb 2016 | •••• |
Complete acquisition details for BioAgilytix
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioAgilytix
9 dated milestones of BioAgilytix across 13 years, from founding to its latest funding, stage changes and deals.
- Founded BioAgilytix is founded.
- Exit Acquired by Riverside Partners.
- Acquisition Acquires IPM Biotech.
- Exit Acquired by Cobepa.
- Funding First funding round.
- Acquisition Acquires Cambridge Biomedical.
- Acquisition Acquires 360biolabs.
- Acquisition Acquires MicroConstants.
- Exit Acquired by Cinven.
Competitors of BioAgilytix
BioAgilytix has 3 listed competitors in our database, 1 of them funded. They include Advion, Evans Analytical Group and ApoCell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| eag.com | 1978 | San Diego, United States | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | ||
| apocell.com | 2004 | Houston, United States | 2,198 | Provider of clinical trial and clinical development on bioanalytical services |
Detailed competitors of BioAgilytix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioAgilytix
The website of BioAgilytix (bioagilytix.com) receives about 41.6K visits a month and ranks #919,146 among all websites worldwide, #1,107 in Biotechnology and Pharmaceuticals.
- Monthly visits41.6K
▲ 16.4% vs previous month
- Unique visitors16.3K
per month
- Global rank#919,146
among all websites
- Category rank#1,107
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.5
- Average visit17 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with BioAgilytix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sherlock.bio | 100% | 2.8K | #4,929,420 | View details | |
| vividion.com | 99% | 4.3K | #4,498,113 | View details | |
| ornatx.com | 99% | 4.4K | #3,250,511 | View details | |
| nebiolab.com | 99% | 20.8K | #944,903 | View details | |
| cuebiopharma.com | 98% | 4.9K | #7,063,180 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for BioAgilytix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as BioAgilytix (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioagilytix
Complete news archive for BioAgilytix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioAgilytix
BioAgilytix was founded in 2008 and raised its 1st funding round 11 years after it was founded.
BioAgilytix is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
BioAgilytix was founded in 2008 and is headquartered in Durham, North Carolina, within the Research Triangle Park area. Operations are conducted as a bioanalytical contract research organization in the biotechnology sector. Services encompass assay development, validation, and sample analysis for immunoassays and cell-based assays, performed under non-GLP, spirit-of-GLP, and GLP guidelines. GMP-compliant product release testing is also handled to support clinical trials for therapeutic biologics and biosimilars.
BioAgilytix's top competitors include Advion, ApoCell and Evans Analytical Group.
BioAgilytix offers Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing.
BioAgilytix has made 4 acquisitions, including 360biolabs, Cambridge Biomedical, and IPM Biotech.
BioAgilytix has 4 investors. Key investors include GHO Capital, Riverside Partners, Cobepa, and Cinven.
BioAgilytix operates through Bioagilytix Labs, Inc..
Yes. BioAgilytix was acquired by Cinven in November 2021.

